Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
Inspire Medical Systems, Inc. (INSP) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding of $160.69 million as of 2023-12-31, per its 10-K filed 2024-02-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding · last filed 2024-02-09
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $160.69M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $372.07M.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $248.35M.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $437.73M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding as first filed |
|---|---|---|
| 2023-12-31 | $160.69M 10-K · filed 2024-02-09 | |
| 2022-12-31 | $372.07M 10-K · filed 2024-02-09 | |
| 2022-06-30 | $248.35M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $437.73M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $397.01M 10-K · filed 2024-02-09 | |
| 2021-09-30 | $416.51M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $327.81M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $374.71M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $351.63M 10-K · filed 2024-02-09 | |
| 2020-09-30 | $225.64M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $133.81M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $76.04M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $124.58M 10-K · filed 2023-02-10 | |
| 2019-09-30 | $96.34M 10-Q · filed 2019-11-05 | |
| 2018-12-31 | $81.45M 10-K · filed 2021-02-24 | |
| 2018-06-30 | $103.98M 10-Q · filed 2019-08-06 | $71.34M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $115.77M 10-Q · filed 2019-05-07 | |
| 2017-09-30 | $84.14M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |